Market Overview:
The global contract development and manufacturing organization (CDMO) outsourcing market is expected to grow at a CAGR of 9.5% from 2018 to 2030. The growth in the CDMO outsourcing market can be attributed to the increasing demand for contract development and manufacturing services from biopharmaceutical companies. In addition, the growing number of blockbuster drugs going off-patent is also contributing to the growth of the CDMO outsourcing market. The small molecules segment is expected to dominate the global CDMO outsourcing market during the forecast period. This can be attributed to factors such as shorter timelines for drug development and commercialization, lower costs, and easy scalability as compared with biologics.
Product Definition:
A Contract Development and Manufacturing Organization (CDMO) Outsourcing is a business arrangement in which one company provides another company with the resources to develop a product or service. The importance of Contract Development and Manufacturing Organization (CDMO) Outsourcing lies in the fact that it can help businesses save time and money while still getting their products to market.
Small Molecules:
Small molecules are the most basic and common type of biologic drugs. They account for more than 90% of all drug prescriptions. Small molecule drugs can be administered to patients without any problems related to food intake or body weight gain, unlike some other types of medication such as peptides and proteins which have an adverse effect on weight gain when taken by mouth.
Biologics:
Biologics is the new term in the life science industry which refers to products derived from living organisms. Biologics includes vaccines, monoclonal antibodies, and other products like insulin for diabetes that have therapeutic value. The major advantage of biologics over conventional drugs is that biologic drugs are more specific and effective in treating a particular disease as compared to synthetic chemicals.
Application Insights:
The contract manufacturing segment held the largest market share in 2017 and is anticipated to grow at a lucrative CAGR during the forecast period. The growth can be attributed to factors such as an increase in demand for complex drugs, growing complexity of drug molecules, and need for high precision of manufactured products.
CDMOs have various advantages including economies of scale, flexibility & agility, expertise in handling large projects & portfolio management among others. Outsourcing CDMO services allows companies to focus on their core business by taking advantage of its capabilities while incurring less risk due to proven track record. This trend is expected to continue over the forecast period with rising adoption across several industry verticals such as biotechnology and pharmaceuticals among others.
Regional Analysis:
North America dominated the global market in 2017. The U.S.-based companies are focusing on R&D and innovation to develop new drugs and medical devices, which is expected to drive the demand for contract development & manufacturing organization (CDMO) services in North America over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising healthcare expenditure, increasing investment by pharmaceutical companies for drug discovery & development, growing biotechnology sector especially in India and China as well as favorable government initiatives pertaining towards outsourcing activities.
Growth Factors:
- Increasing demand for biologics and biosimilars: The global market for biologics is expected to grow at a CAGR of over 10% from 2016 to 2020. This is primarily due to the increasing prevalence of chronic diseases, rising awareness about available treatments, and the launch of novel therapies. The market for biosimilars is also expected to grow rapidly in the next few years as more countries adopt these drugs. This will create opportunities for CDMOs that specialize in manufacturing biologic and biosimilar products.
- Growing demand for contract services: There has been a growing trend among pharmaceutical companies to outsource certain aspects of their operations, including contract development and manufacturing services (CDMOs). This is because outsourcing allows companies to focus on their core competencies while relying on CDMOs for specialized expertise and support. The trend is likely to continue in the coming years as pharmaceutical companies seek ways to reduce costs and improve efficiency.
- Expansion of emerging markets: A large number of emerging markets are experiencing rapid economic growth, which is leading to an increase in healthcare spending levels. This provides opportunities for CDMOs that are looking to expand into new markets or establish themselves in existing ones. In addition, many developed countries are tightening regulations governing drug approvals, which is creating opportunities for CDMOs that offer regulatory consulting services or have experience with complex drug formulations/manufacturing processes .
Scope Of The Report
Report Attributes
Report Details
Report Title
Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Research Report
By Type
Small Molecules, Biologics
By Application
Contract Development, Contract Manufacturing
By Companies
Aenova Holding GmbH, Almac Group Ltd., Catalent Inc., FAMAR Health Care Services, FAREVA SA, Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., Thermo Fisher Scientific Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Report Segments:
The global Contract Development and Manufacturing Organization (CDMO) Outsourcing market is segmented on the basis of:
Types
Small Molecules, Biologics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Contract Development, Contract Manufacturing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aenova Holding GmbH
- Almac Group Ltd.
- Catalent Inc.
- FAMAR Health Care Services
- FAREVA SA
- Lonza Group Ltd.
- Recipharm AB
- Siegfried Holding AG
- The Lubrizol Corp.
- Thermo Fisher Scientific Inc.
Highlights of The Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Molecules
- Biologics
- By Application:
- Contract Development
- Contract Manufacturing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contract Development and Manufacturing Organization (CDMO) Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Contract development and manufacturing organization (CDMO) outsourcing is the process of contracting out the development or manufacture of products or services. CDMOs can provide a variety of services, such as software design, engineering, manufacturing, and marketing.
Some of the key players operating in the contract development and manufacturing organization (cdmo) outsourcing market are Aenova Holding GmbH, Almac Group Ltd., Catalent Inc., FAMAR Health Care Services, FAREVA SA, Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., Thermo Fisher Scientific Inc..
The contract development and manufacturing organization (cdmo) outsourcing market is expected to grow at a compound annual growth rate of 9.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Contract Development and Manufacturing Organization (CDMO) Outsourcing Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size & Forecast, 2018-2028 4.5.1 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size and Y-o-Y Growth 4.5.2 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Absolute $ Opportunity
Chapter 5 Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Type
5.2.1 Small Molecules
5.2.2 Biologics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Applications
6.2.1 Contract Development
6.2.2 Contract Manufacturing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Contract Development and Manufacturing Organization (CDMO) Outsourcing Analysis and Forecast
9.1 Introduction
9.2 North America Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Type
9.6.1 Small Molecules
9.6.2 Biologics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Applications
9.10.1 Contract Development
9.10.2 Contract Manufacturing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Contract Development and Manufacturing Organization (CDMO) Outsourcing Analysis and Forecast
10.1 Introduction
10.2 Europe Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Type
10.6.1 Small Molecules
10.6.2 Biologics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Applications
10.10.1 Contract Development
10.10.2 Contract Manufacturing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Contract Development and Manufacturing Organization (CDMO) Outsourcing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Type
11.6.1 Small Molecules
11.6.2 Biologics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Applications
11.10.1 Contract Development
11.10.2 Contract Manufacturing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Contract Development and Manufacturing Organization (CDMO) Outsourcing Analysis and Forecast
12.1 Introduction
12.2 Latin America Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Type
12.6.1 Small Molecules
12.6.2 Biologics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Applications
12.10.1 Contract Development
12.10.2 Contract Manufacturing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Contract Development and Manufacturing Organization (CDMO) Outsourcing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Type
13.6.1 Small Molecules
13.6.2 Biologics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size Forecast by Applications
13.10.1 Contract Development
13.10.2 Contract Manufacturing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Contract Development and Manufacturing Organization (CDMO) Outsourcing Market: Competitive Dashboard
14.2 Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aenova Holding GmbH
14.3.2 Almac Group Ltd.
14.3.3 Catalent Inc.
14.3.4 FAMAR Health Care Services
14.3.5 FAREVA SA
14.3.6 Lonza Group Ltd.
14.3.7 Recipharm AB
14.3.8 Siegfried Holding AG
14.3.9 The Lubrizol Corp.
14.3.10 Thermo Fisher Scientific Inc.